On day 3 following lithium-pilocarpine administration (compared with controls), the majority of regulated signaling pathways were as follows: Huntington’s disease, tumor necrosis factor (TNF) signaling, tight junction, and nuclear factor (NF)-kappa B pathways. The gene discussed is TNF; the disease is Huntington disease.